DISEASES Of Interest
Comprehensive Research For Diseases of Interest
Improving quality of life by supporting the accessibility of new treatments in research trials.
Diseases of Interest
At LEADER research, our mission is to advance the understanding and treatment of various diseases through dedicated clinical research. We focus on conditions that significantly impact patients' quality of life.
Disease of Interest
Atopic Dermatitis (Eczema)
Atopic dermatitis (eczema) is a chronic skin condition that causes patches and/or rashes that are red and itchy. It is exacerbated when the skin is dry and cracked. Atopic dermatitis is commonly associated with allergies and asthma.
Disease of Interest
Hidradenitis Suppurativa
Hidradenitis suppurativa is a chronic skin condition that results in boil-like lumps that frequently develop and leak on the areas of the body where skin rubs together, such as the armpits, groin region, and under the breasts.
Disease of Interest
Chronic Spontaneous Urticaria (Hives)
Chronic Spontaneous Urticaria (Hives) is a condition causing recurrent itchy hives and swelling without a known trigger, lasting for six weeks or more.
Disease of Interest
Chronic Inducible Urticaria (CIndU): Dermographism, Cold, And Cholinergic
Chronic Inducible Urticaria (CIndU) includes types like dermographism, cold urticaria, and cholinergic urticaria, where hives are triggered by physical stimuli like skin pressure, cold temperatures, or heat and exercise.
Disease of Interest
Nonsegmental Vitiligo
Nonsegmental vitiligo is a skin condition characterized by the loss of pigment in patches, often symmetrically, due to the immune system attacking pigment-producing cells.
Disease of Interest
Alopecia Areata
Alopecia areata is an autoimmune condition that causes sudden, patchy hair loss on the scalp and other parts of the body. The immune system attacks hair follicles, leading to hair thinning or bald patches.
Disease of Interest
Plaque Psoriasis
Psoriasis is a chronic autoimmune skin condition that results in itchy, dry, raised skin patches (plaques) covered with gray or silver scales, commonly affecting the knees, elbows, trunk, and scalp, frequently, causing discomfort.
Actively Recruiting Trials
CLINICAL TRIAL
Phase 2 | Injection | 32 weeks
Atopic Dermatitis
(Eczema) Trial
- ≥ 18 years olds
RECRUITING
RECRUITING
CLINICAL TRIAL
Phase 3b | Oral tablet | 52 weeks
Chronic Spontaneous Urticaria
(Hives) Trial
Phase 2 | Injection | 32 weeks
CLINICAL TRIAL
- Between 18 and 70 years old
Hidradenitis Suppurativa Trial
Phase 3 | Oral tablet | 108 weeks
- ≥ 12 years old
Phase 3 | Oral tablet | 54 weeks
Hidradenitis Suppurativa Trial
Trial ID: NCT06113445
CLINICAL TRIAL
- ≥ 18 years old
Trial ID: NCT05976243
Phase 2 | Injection | 52 weeks
Chronis Inducible Urticaria (CIndU): Dermographism Cold, And Cholinergic Trial
Trial ID: NCT06444451
Phase 3 | Injection | 16-62 weeks
RECRUITING
Hidradenitis Suppurativa Trial
Alopecia Areata
Trial
RECRUITING
- ≥ 18 years old
Phase 3 | Oral tablet | 64 weeks
CLINICAL TRIAL
Hidradenitis Suppurativa Trial
Trial ID: NCT05889182
Phase 3 | Oral tablet | 88 weeks
RECRUITING
- ≥ 12 years old
CLINICAL TRIAL
RECRUITING
Atopic Dermatitis
(Eczema) Trial
Trial ID: NCT05995964
Phase 2 | Injection | 40 weeks
- ≥ 18 years old
CLINICAL TRIAL
RECRUITING
Atopic Dermatitis
(Eczema) Trial
Trial ID: NCT06241118
Phase 3 | Injection | 56 weeks
- ≥ 12 years old
CLINICAL TRIAL
RECRUITING
Hidradenitis Suppurativa Trial
Trial ID: NCT06468228
Phase 3 | Injection | 52 weeks
- ≥ 16 years old
CLINICAL TRIAL
RECRUITING
Plaque Psoriasis
Trial
Trial ID: NCT06550076
Phase 3 | Oral tablet | 52 weeks
- ≥ 18 years old
CLINICAL TRIAL
Chronic Spontaneous Urticaria
(Hives) Trial
Phase 3b | Oral tablet | 112 weeks
Trial ID: NCT06042478
RECRUITING
- ≥ 18 years old
CLINICAL TRIAL
RECRUITING
Chronic Spontaneous
Urticaria
(Hives) Trial
Trial ID: NCT06455202
Phase 3 | Injection | 44 weeks
- ≥ 18 years old
CLINICAL TRIAL
RECRUITING
Chronic Inducible Urticaria (CIndU): Cholinergic Trial
Trial ID: NCT05976243
Phase 3 | Oral tablet | 60 weeks
- ≥ 18 years old
CLINICAL TRIAL
RECRUITING
Hidradenitis Suppurativa Trial
Trial ID: NCT06603077
Phase 2 | Injection | 14 weeks
- ≥ 18 years old
Trials Coming Soon (placeholder)
CLINICAL TRIAL
UPCOMING
Disease Of Interest
Trial
Phase X | Injection | XX week treatment period | XX week safety follow up
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
Trial ID: XXXXXXXXXXX
Exclusion Criteria:
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
CLINICAL TRIAL
UPCOMING
Disease Of Interest
Trial
Trial ID: XXXXXXXXXXX
Phase X | Injection | XX week treatment period | XX week safety follow up
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
Exclusion Criteria:
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
CLINICAL TRIAL
UPCOMING
Disease Of Interest
Trial
Trial ID: XXXXXXXXXXX
Phase X | Injection | XX week treatment period | XX week safety follow up
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
Exclusion Criteria:
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
- Lorem ipsum dolor sit amet, consectetur adipiscing elit
Contact Us
Quick Links
All Rights Reserved | LEADER Research